Specify a stock or a cryptocurrency in the search bar to get a summary
Windlas Biotech Limited
WINDLASWindlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India. Address: 705-706, Vatika Professional Point, Gurugram, India, 122001
Analytics
WallStreet Target Price
–P/E ratio
38.5019Dividend Yield
0.52 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures WINDLAS
Dividend Analytics WINDLAS
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
20 %Dividend History WINDLAS
Stock Valuation WINDLAS
Financials WINDLAS
Results | 2019 | Dynamics |